25 XP   0   0   10

Baolingbao Biology Co Ltd
Buy, Hold or Sell?

Let's analyse Baolingbao Biology Co Ltd together

PenkeI guess you are interested in Baolingbao Biology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Baolingbao Biology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Baolingbao Biology Co Ltd

I send you an email if I find something interesting about Baolingbao Biology Co Ltd.

Quick analysis of Baolingbao Biology Co Ltd (30 sec.)










What can you expect buying and holding a share of Baolingbao Biology Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥5.35
Expected worth in 1 year
¥5.31
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
¥0.17
Return On Investment
3.2%

For what price can you sell your share?

Current Price per Share
¥5.45
Expected price per share
¥4.5663816793893 - ¥6.49
How sure are you?
50%

1. Valuation of Baolingbao Biology Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥5.45

Intrinsic Value Per Share

¥1.50 - ¥1.80

Total Value Per Share

¥6.85 - ¥7.15

2. Growth of Baolingbao Biology Co Ltd (5 min.)




Is Baolingbao Biology Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$274.1m$263.7m$13.9m5.0%

How much money is Baolingbao Biology Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.8m$4.6m-$2.7m-146.8%
Net Profit Margin2.1%4.9%--

How much money comes from the company's main activities?

3. Financial Health of Baolingbao Biology Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#188 / 1016

Most Revenue
#108 / 1016

Most Profit
#142 / 1016

Most Efficient
#153 / 1016

What can you expect buying and holding a share of Baolingbao Biology Co Ltd? (5 min.)

Welcome investor! Baolingbao Biology Co Ltd's management wants to use your money to grow the business. In return you get a share of Baolingbao Biology Co Ltd.

What can you expect buying and holding a share of Baolingbao Biology Co Ltd?

First you should know what it really means to hold a share of Baolingbao Biology Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Baolingbao Biology Co Ltd is ¥5.45. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Baolingbao Biology Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Baolingbao Biology Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.35. Based on the TTM, the Book Value Change Per Share is ¥-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Baolingbao Biology Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.1%0.000.1%0.010.2%0.010.2%0.010.1%
Usd Book Value Change Per Share-0.01-0.1%0.000.0%0.020.3%0.010.2%0.010.1%
Usd Dividend Per Share0.000.0%0.010.1%0.000.1%0.000.1%0.000.1%
Usd Total Gains Per Share-0.01-0.1%0.010.1%0.020.4%0.010.2%0.010.2%
Usd Price Per Share1.12-1.19-1.44-1.31-1.49-
Price to Earnings Ratio94.31-64.86-32.06-25.44-52.27-
Price-to-Total Gains Ratio-195.07--135.00-76.56--75.45-74.90-
Price to Book Ratio1.52-1.60-2.04-2.02-2.51-
Price-to-Total Gains Ratio-195.07--135.00-76.56--75.45-74.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.75319
Number of shares1327
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.010.01
Gains per Quarter (1327 shares)7.8916.59
Gains per Year (1327 shares)31.5466.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
139-822234456
278-15544587122
3117-238668131188
4156-3011891175254
5195-38150113218320
6234-45182136262386
7274-53214159306452
8313-60246181349518
9352-68278204393584
10391-75310227437650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%36.03.01.090.0%54.03.01.093.1%
Book Value Change Per Share1.03.00.025.0%9.03.00.075.0%15.05.00.075.0%30.010.00.075.0%48.010.00.082.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%53.00.05.091.4%
Total Gains per Share2.02.00.050.0%10.02.00.083.3%16.04.00.080.0%34.06.00.085.0%52.06.00.089.7%

Fundamentals of Baolingbao Biology Co Ltd

About Baolingbao Biology Co Ltd

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, including oligomaltose, fructose syrup, solid corn syrup, maltodextrin, and glucose syrup; and animal nutrition products comprising baolekang and fubaokang. Its products are used in various applications, such as dairy products, drinks, snacks, health products and dietary supplements, candy, special food items, chemicals for daily use, and animal nutrition. The company also exports its products. Baolingbao Biology Co.,Ltd. was founded in 1997 and is based in Yucheng, China.

Fundamental data was last updated by Penke on 2024-04-14 14:38:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Baolingbao Biology Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Baolingbao Biology Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 1.4% means that ¥0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Baolingbao Biology Co Ltd:

  • The MRQ is 1.4%. The company is making a profit. +1
  • The TTM is 2.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.4%TTM2.1%-0.7%
TTM2.1%YOY4.9%-2.8%
TTM2.1%5Y3.6%-1.5%
5Y3.6%10Y3.4%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4%-199.6%+201.0%
TTM2.1%-213.0%+215.1%
YOY4.9%-279.3%+284.2%
5Y3.6%-438.4%+442.0%
10Y3.4%-605.5%+608.9%
1.1.2. Return on Assets

Shows how efficient Baolingbao Biology Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • 0.3% Return on Assets means that Baolingbao Biology Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.5%-0.2%
TTM0.5%YOY1.1%-0.7%
TTM0.5%5Y0.8%-0.4%
5Y0.8%10Y0.7%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%-13.5%+13.8%
TTM0.5%-12.9%+13.4%
YOY1.1%-11.8%+12.9%
5Y0.8%-14.1%+14.9%
10Y0.7%-16.0%+16.7%
1.1.3. Return on Equity

Shows how efficient Baolingbao Biology Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • 0.4% Return on Equity means Baolingbao Biology Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.7%-0.3%
TTM0.7%YOY1.8%-1.1%
TTM0.7%5Y1.3%-0.7%
5Y1.3%10Y1.0%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%-16.9%+17.3%
TTM0.7%-16.1%+16.8%
YOY1.8%-15.1%+16.9%
5Y1.3%-19.9%+21.2%
10Y1.0%-20.9%+21.9%

1.2. Operating Efficiency of Baolingbao Biology Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Baolingbao Biology Co Ltd is operating .

  • Measures how much profit Baolingbao Biology Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.9%-0.9%
TTM0.9%YOY6.3%-5.4%
TTM0.9%5Y4.4%-3.5%
5Y4.4%10Y2.4%+2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM0.9%-225.8%+226.7%
YOY6.3%-288.4%+294.7%
5Y4.4%-477.4%+481.8%
10Y2.4%-625.6%+628.0%
1.2.2. Operating Ratio

Measures how efficient Baolingbao Biology Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.94 means that the operating costs are ¥1.94 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 1.940. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.884. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.940TTM1.884+0.056
TTM1.884YOY1.823+0.062
TTM1.8845Y1.836+0.048
5Y1.83610Y1.404+0.433
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9403.090-1.150
TTM1.8843.264-1.380
YOY1.8233.783-1.960
5Y1.8365.679-3.843
10Y1.4047.894-6.490

1.3. Liquidity of Baolingbao Biology Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Baolingbao Biology Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.36 means the company has ¥1.36 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 1.363. The company is just able to pay all its short-term debts.
  • The TTM is 1.307. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.363TTM1.307+0.056
TTM1.307YOY1.450-0.143
TTM1.3075Y1.195+0.113
5Y1.19510Y0.679+0.516
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3633.914-2.551
TTM1.3074.220-2.913
YOY1.4505.388-3.938
5Y1.1956.045-4.850
10Y0.6796.406-5.727
1.3.2. Quick Ratio

Measures if Baolingbao Biology Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.40 means the company can pay off ¥0.40 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.397. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.373. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.397TTM0.373+0.025
TTM0.373YOY0.451-0.078
TTM0.3735Y0.335+0.038
5Y0.33510Y0.346-0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3973.572-3.175
TTM0.3733.998-3.625
YOY0.4515.390-4.939
5Y0.3355.969-5.634
10Y0.3466.287-5.941

1.4. Solvency of Baolingbao Biology Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Baolingbao Biology Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Baolingbao Biology Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that Baolingbao Biology Co Ltd assets are financed with 25.4% credit (debt) and the remaining percentage (100% - 25.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.254. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.291. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.254TTM0.291-0.037
TTM0.291YOY0.353-0.062
TTM0.2915Y0.369-0.079
5Y0.36910Y0.306+0.063
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2540.336-0.082
TTM0.2910.334-0.043
YOY0.3530.269+0.084
5Y0.3690.366+0.003
10Y0.3060.390-0.084
1.4.2. Debt to Equity Ratio

Measures if Baolingbao Biology Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 34.1% means that company has ¥0.34 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Baolingbao Biology Co Ltd:

  • The MRQ is 0.341. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.412. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.341TTM0.412-0.071
TTM0.412YOY0.547-0.135
TTM0.4125Y0.595-0.184
5Y0.59510Y0.466+0.130
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3410.382-0.041
TTM0.4120.396+0.016
YOY0.5470.335+0.212
5Y0.5950.434+0.161
10Y0.4660.465+0.001

2. Market Valuation of Baolingbao Biology Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Baolingbao Biology Co Ltd generates.

  • Above 15 is considered overpriced but always compare Baolingbao Biology Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 94.31 means the investor is paying ¥94.31 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Baolingbao Biology Co Ltd:

  • The EOD is 63.298. Based on the earnings, the company is expensive. -2
  • The MRQ is 94.308. Based on the earnings, the company is expensive. -2
  • The TTM is 64.858. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD63.298MRQ94.308-31.010
MRQ94.308TTM64.858+29.450
TTM64.858YOY32.065+32.793
TTM64.8585Y25.440+39.418
5Y25.44010Y52.269-26.829
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD63.298-2.259+65.557
MRQ94.308-2.569+96.877
TTM64.858-2.664+67.522
YOY32.065-4.120+36.185
5Y25.440-6.258+31.698
10Y52.269-6.171+58.440
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Baolingbao Biology Co Ltd:

  • The EOD is 10.652. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 15.870. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -52.087. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.652MRQ15.870-5.218
MRQ15.870TTM-52.087+67.957
TTM-52.087YOY-8.357-43.729
TTM-52.0875Y61.433-113.519
5Y61.43310Y30.716+30.716
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.652-2.924+13.576
MRQ15.870-3.246+19.116
TTM-52.087-3.488-48.599
YOY-8.357-5.620-2.737
5Y61.433-8.315+69.748
10Y30.716-8.826+39.542
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Baolingbao Biology Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.52 means the investor is paying ¥1.52 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Baolingbao Biology Co Ltd:

  • The EOD is 1.019. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.518. Based on the equity, the company is underpriced. +1
  • The TTM is 1.596. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.019MRQ1.518-0.499
MRQ1.518TTM1.596-0.078
TTM1.596YOY2.037-0.442
TTM1.5965Y2.017-0.421
5Y2.01710Y2.508-0.491
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0191.851-0.832
MRQ1.5182.090-0.572
TTM1.5962.095-0.499
YOY2.0372.844-0.807
5Y2.0173.466-1.449
10Y2.5083.815-1.307
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Baolingbao Biology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.051-0.010-80%0.129-140%0.060-186%0.037-239%
Book Value Per Share--5.3505.415-1%5.131+4%4.729+13%4.380+22%
Current Ratio--1.3631.307+4%1.450-6%1.195+14%0.679+101%
Debt To Asset Ratio--0.2540.291-13%0.353-28%0.369-31%0.306-17%
Debt To Equity Ratio--0.3410.412-17%0.547-38%0.595-43%0.466-27%
Dividend Per Share--0.0100.053-82%0.035-72%0.031-68%0.034-71%
Eps--0.0220.035-39%0.090-76%0.064-66%0.046-53%
Free Cash Flow Per Share--0.1280.088+46%-0.150+218%0.048+164%0.048+164%
Free Cash Flow To Equity Per Share--0.128-0.045+135%-0.108+184%0.014+789%0.014+789%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--1.804--------
Intrinsic Value_10Y_min--1.504--------
Intrinsic Value_1Y_max--0.042--------
Intrinsic Value_1Y_min--0.041--------
Intrinsic Value_3Y_max--0.232--------
Intrinsic Value_3Y_min--0.220--------
Intrinsic Value_5Y_max--0.550--------
Intrinsic Value_5Y_min--0.501--------
Market Cap2020701993.600-49%3010660584.9603206735298.370-6%3871377901.500-22%3522187822.902-15%3997306553.451-25%
Net Profit Margin--0.0140.021-33%0.049-71%0.036-61%0.034-59%
Operating Margin---0.009-100%0.063-100%0.044-100%0.024-100%
Operating Ratio--1.9401.884+3%1.823+6%1.836+6%1.404+38%
Pb Ratio1.019-49%1.5181.596-5%2.037-25%2.017-25%2.508-39%
Pe Ratio63.298-49%94.30864.858+45%32.065+194%25.440+271%52.269+80%
Price Per Share5.450-49%8.1208.643-6%10.410-22%9.490-14%10.776-25%
Price To Free Cash Flow Ratio10.652-49%15.870-52.087+428%-8.357+153%61.433-74%30.716-48%
Price To Total Gains Ratio-130.925+33%-195.067-135.001-31%76.557-355%-75.448-61%74.898-360%
Quick Ratio--0.3970.373+7%0.451-12%0.335+19%0.346+15%
Return On Assets--0.0030.005-36%0.011-73%0.008-64%0.007-56%
Return On Equity--0.0040.007-40%0.018-77%0.013-70%0.010-61%
Total Gains Per Share---0.0420.043-197%0.164-125%0.090-146%0.071-159%
Usd Book Value--274117739.915277653202.941-1%263700806.377+4%242563926.578+13%224561240.656+22%
Usd Book Value Change Per Share---0.007-0.001-80%0.018-140%0.008-186%0.005-239%
Usd Book Value Per Share--0.7390.748-1%0.709+4%0.654+13%0.605+22%
Usd Dividend Per Share--0.0010.007-82%0.005-72%0.004-68%0.005-71%
Usd Eps--0.0030.005-39%0.012-76%0.009-66%0.006-53%
Usd Free Cash Flow--6554215.7184493293.543+46%-7729673.988+218%1978176.394+231%989088.197+563%
Usd Free Cash Flow Per Share--0.0180.012+46%-0.021+218%0.007+164%0.007+164%
Usd Free Cash Flow To Equity Per Share--0.018-0.006+135%-0.015+184%0.002+789%0.002+789%
Usd Market Cap279261015.516-49%416073292.841443170818.235-6%535024425.987-22%486766357.125-15%552427765.687-25%
Usd Price Per Share0.753-49%1.1221.194-6%1.439-22%1.312-14%1.489-25%
Usd Profit--1102964.5411864629.631-41%4600983.391-76%3274046.881-66%2376018.611-54%
Usd Revenue--77239728.20287201228.967-11%93725350.714-18%81962167.868-6%64502630.452+20%
Usd Total Gains Per Share---0.0060.006-197%0.023-125%0.013-146%0.010-159%
 EOD+5 -3MRQTTM+11 -24YOY+12 -235Y+15 -2010Y+17 -19

3.2. Fundamental Score

Let's check the fundamental score of Baolingbao Biology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1563.298
Price to Book Ratio (EOD)Between0-11.019
Net Profit Margin (MRQ)Greater than00.014
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.397
Current Ratio (MRQ)Greater than11.363
Debt to Asset Ratio (MRQ)Less than10.254
Debt to Equity Ratio (MRQ)Less than10.341
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.003
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Baolingbao Biology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.061
Ma 20Greater thanMa 506.039
Ma 50Greater thanMa 1005.904
Ma 100Greater thanMa 2006.898
OpenGreater thanClose5.500
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,658,892
Total Liabilities675,407
Total Stockholder Equity1,983,486
 As reported
Total Liabilities 675,407
Total Stockholder Equity+ 1,983,486
Total Assets = 2,658,892

Assets

Total Assets2,658,892
Total Current Assets785,867
Long-term Assets1,873,025
Total Current Assets
Cash And Cash Equivalents 242,736
Net Receivables 229,110
Inventory 278,582
Other Current Assets 216
Total Current Assets  (as reported)785,867
Total Current Assets  (calculated)750,645
+/- 35,223
Long-term Assets
Property Plant Equipment 1,432,683
Intangible Assets 121,281
Long-term Assets Other 1,905
Long-term Assets  (as reported)1,873,025
Long-term Assets  (calculated)1,555,869
+/- 317,156

Liabilities & Shareholders' Equity

Total Current Liabilities576,475
Long-term Liabilities98,932
Total Stockholder Equity1,983,486
Total Current Liabilities
Short Long Term Debt 209,814
Accounts payable 237,559
Other Current Liabilities 1,085
Total Current Liabilities  (as reported)576,475
Total Current Liabilities  (calculated)448,458
+/- 128,017
Long-term Liabilities
Long term Debt 37,900
Capital Lease Obligations Min Short Term Debt245
Long-term Liabilities  (as reported)98,932
Long-term Liabilities  (calculated)38,145
+/- 60,787
Total Stockholder Equity
Retained Earnings 648,203
Total Stockholder Equity (as reported)1,983,486
Total Stockholder Equity (calculated)648,203
+/- 1,335,283
Other
Capital Stock370,771
Common Stock Shares Outstanding 370,771
Net Debt 4,978
Net Invested Capital 2,231,199
Net Working Capital 209,393
Property Plant and Equipment Gross 2,334,392



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302008-12-312007-12-312006-12-31
> Total Assets 
507,933
601,896
743,907
778,695
1,246,571
1,084,110
1,157,299
1,083,156
1,090,448
1,032,573
1,078,038
1,089,621
1,085,730
1,112,589
1,100,262
1,157,060
1,117,851
1,112,767
1,135,467
1,694,273
1,669,354
1,675,390
1,682,231
1,669,940
1,695,827
1,766,097
1,872,006
1,934,255
1,858,773
1,913,550
1,915,038
1,912,447
1,911,007
1,931,564
1,945,515
1,991,032
2,015,436
2,106,920
2,290,365
2,560,131
2,467,184
2,579,253
2,707,575
2,768,535
2,580,425
2,518,762
2,621,306
2,573,108
2,493,722
2,615,727
2,807,840
2,879,307
2,912,556
3,028,996
2,914,408
3,009,685
2,867,044
3,006,135
3,003,533
2,929,216
2,758,376
2,658,892
2,658,8922,758,3762,929,2163,003,5333,006,1352,867,0443,009,6852,914,4083,028,9962,912,5562,879,3072,807,8402,615,7272,493,7222,573,1082,621,3062,518,7622,580,4252,768,5352,707,5752,579,2532,467,1842,560,1312,290,3652,106,9202,015,4361,991,0321,945,5151,931,5641,911,0071,912,4471,915,0381,913,5501,858,7731,934,2551,872,0061,766,0971,695,8271,669,9401,682,2311,675,3901,669,3541,694,2731,135,4671,112,7671,117,8511,157,0601,100,2621,112,5891,085,7301,089,6211,078,0381,032,5731,090,4481,083,1561,157,2991,084,1101,246,571778,695743,907601,896507,933
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,139,733
1,014,111
926,552
1,020,511
1,179,343
994,228
945,567
1,049,256
1,021,854
940,559
1,008,156
1,200,989
1,241,277
1,272,188
1,314,886
1,191,474
1,218,301
1,051,600
995,777
993,199
971,071
852,056
785,867
785,867852,056971,071993,199995,7771,051,6001,218,3011,191,4741,314,8861,272,1881,241,2771,200,9891,008,156940,5591,021,8541,049,256945,567994,2281,179,3431,020,511926,5521,014,1111,139,733000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
580,054
367,528
416,276
439,428
564,208
430,750
415,992
495,161
491,158
544,165
485,251
571,835
557,302
595,158
585,440
377,116
375,155
468,093
375,949
332,200
312,799
287,654
242,736
242,736287,654312,799332,200375,949468,093375,155377,116585,440595,158557,302571,835485,251544,165491,158495,161415,992430,750564,208439,428416,276367,528580,054000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
0
0
0
0
0
0
0
0
0
0
0
32,528
99,104
106,670
108,575
114,176
13,872
0
0
0
0
0
0000013,872114,176108,575106,67099,10432,5280000000000020,000000000000000000000000000000000000000000
       Net Receivables 
62,210
46,367
60,432
82,126
83,089
75,412
132,819
104,661
104,365
133,418
111,086
134,198
113,342
132,365
125,726
147,326
125,217
140,132
139,205
100,505
104,287
111,988
108,046
104,455
94,636
90,814
123,137
142,368
133,449
121,859
146,512
125,283
164,029
132,535
167,095
157,809
167,689
165,769
168,462
205,152
215,318
275,246
203,296
208,228
178,925
325,693
311,838
283,657
203,908
290,116
327,485
285,138
330,505
303,291
325,383
312,883
274,122
250,797
239,415
284,791
269,204
229,110
229,110269,204284,791239,415250,797274,122312,883325,383303,291330,505285,138327,485290,116203,908283,657311,838325,693178,925208,228203,296275,246215,318205,152168,462165,769167,689157,809167,095132,535164,029125,283146,512121,859133,449142,368123,13790,81494,636104,455108,046111,988104,287100,505139,205140,132125,217147,326125,726132,365113,342134,198111,086133,418104,365104,661132,81975,41283,08982,12660,43246,36762,210
       Other Current Assets 
11,348
11,638
5,338
19,122
16,038
21,435
18,165
27,112
27,488
26,397
23,086
9,972
10,861
20,707
14,875
3,409
24,669
3,481
11,778
146,483
206,878
214,416
148,229
9,655
167,752
42,870
244,021
57,817
148,508
46,839
165,370
55,538
136,230
24,247
128,099
59,813
153,412
97,219
132,199
131,277
247,848
14,211
6,567
11,919
7,065
18,147
16,999
23,133
11,978
14,910
26,121
30,759
38,089
34,392
39,750
22,982
38,396
33,640
3,099
19,973
17,942
216
21617,94219,9733,09933,64038,39622,98239,75034,39238,08930,75926,12114,91011,97823,13316,99918,1477,06511,9196,56714,211247,848131,277132,19997,219153,41259,813128,09924,247136,23055,538165,37046,839148,50857,817244,02142,870167,7529,655148,229214,416206,878146,48311,7783,48124,6693,40914,87520,70710,8619,97223,08626,39727,48827,11218,16521,43516,03819,1225,33811,63811,348
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,687,064
1,589,192
1,586,197
1,573,195
1,572,050
1,551,254
1,553,163
1,607,572
1,606,851
1,638,030
1,640,368
1,714,110
1,722,933
1,791,384
1,815,444
2,010,359
2,010,334
1,958,145
1,906,320
1,873,025
1,873,0251,906,3201,958,1452,010,3342,010,3591,815,4441,791,3841,722,9331,714,1101,640,3681,638,0301,606,8511,607,5721,553,1631,551,2541,572,0501,573,1951,586,1971,589,1921,687,064000000000000000000000000000000000000000000
       Property Plant Equipment 
185,203
364,928
418,017
480,170
445,400
537,744
450,061
525,654
465,999
614,156
538,530
654,736
566,604
704,176
593,413
707,050
594,571
719,985
608,711
724,953
631,324
814,327
750,000
781,659
830,231
924,311
945,897
969,415
998,269
1,070,372
1,067,701
1,067,453
1,064,083
1,074,034
1,069,351
1,099,460
1,099,243
1,116,218
1,119,819
1,180,180
1,178,270
1,200,609
1,192,799
1,184,642
1,176,080
1,177,019
1,172,767
1,155,295
1,158,645
1,224,364
1,211,195
1,256,256
1,254,689
1,286,352
1,297,089
1,358,120
1,399,142
1,532,285
1,507,895
1,472,924
1,444,704
1,432,683
1,432,6831,444,7041,472,9241,507,8951,532,2851,399,1421,358,1201,297,0891,286,3521,254,6891,256,2561,211,1951,224,3641,158,6451,155,2951,172,7671,177,0191,176,0801,184,6421,192,7991,200,6091,178,2701,180,1801,119,8191,116,2181,099,2431,099,4601,069,3511,074,0341,064,0831,067,4531,067,7011,070,372998,269969,415945,897924,311830,231781,659750,000814,327631,324724,953608,711719,985594,571707,050593,413704,176566,604654,736538,530614,156465,999525,654450,061537,744445,400480,170418,017364,928185,203
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,991
127,341
256,202
294,338
254,881
256,916
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000256,916254,881294,338256,202127,34188,991000000000000000000000000000000000000000
       Intangible Assets 
59,170
61,203
59,796
2,840
58,586
79,250
71,190
2,440
70,264
2,536
111,375
2,299
110,159
2,224
108,018
2,089
106,867
1,922
115,751
1,649
114,618
1,471
112,597
111,845
111,969
110,320
109,589
134,327
133,469
133,000
132,115
143,715
145,117
143,451
142,847
141,917
140,996
140,365
140,826
139,653
138,665
137,677
136,689
3,009
135,495
134,927
133,857
132,787
131,716
133,602
132,506
131,334
130,316
129,266
128,216
127,166
126,115
125,066
124,016
123,006
122,065
121,281
121,281122,065123,006124,016125,066126,115127,166128,216129,266130,316131,334132,506133,602131,716132,787133,857134,927135,4953,009136,689137,677138,665139,653140,826140,365140,996141,917142,847143,451145,117143,715132,115133,000133,469134,327109,589110,320111,969111,845112,5971,471114,6181,649115,7511,922106,8672,089108,0182,224110,1592,299111,3752,53670,2642,44071,19079,25058,5862,84059,79661,20359,170
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
109,999
7,701
7,443
241
1,891
4,537
1,165,124
2,351
14,212
149
2,318
8,890
20,089
32,977
17,020
646
782
2,778
3,988
1,905
1,9053,9882,77878264617,02032,97720,0898,8902,31814914,2122,3511,165,1244,5371,8912417,4437,701109,999000000000000000000000000000000000000000000
> Total Liabilities 
395,403
408,619
505,853
518,966
592,351
421,496
486,335
400,595
395,469
329,460
364,748
357,559
333,138
352,058
326,441
372,588
313,169
295,314
304,898
278,932
241,371
240,877
233,253
217,578
238,694
316,694
407,244
467,555
384,986
435,436
445,754
425,545
411,729
423,431
423,174
476,571
494,675
581,794
754,069
1,027,665
922,757
1,037,269
1,157,462
1,212,805
1,007,879
951,764
1,037,478
973,279
888,172
1,016,368
1,200,318
1,237,735
1,174,229
1,215,764
1,066,584
1,135,323
961,132
1,001,793
965,173
917,334
755,833
675,407
675,407755,833917,334965,1731,001,793961,1321,135,3231,066,5841,215,7641,174,2291,237,7351,200,3181,016,368888,172973,2791,037,478951,7641,007,8791,212,8051,157,4621,037,269922,7571,027,665754,069581,794494,675476,571423,174423,431411,729425,545445,754435,436384,986467,555407,244316,694238,694217,578233,253240,877241,371278,932304,898295,314313,169372,588326,441352,058333,138357,559364,748329,460395,469400,595486,335421,496592,351518,966505,853408,619395,403
   > Total Current Liabilities 
370,311
236,927
282,361
321,699
475,289
360,954
437,530
352,528
359,177
291,360
334,549
327,900
315,374
332,804
307,660
351,305
292,433
268,155
278,510
238,940
202,275
206,275
198,651
179,772
201,786
280,483
372,042
432,955
351,493
402,737
414,171
395,654
378,647
387,820
389,005
440,806
460,475
548,930
718,967
980,995
873,921
984,519
1,098,632
1,156,876
953,360
898,728
986,053
920,301
832,926
956,406
1,128,880
1,167,594
1,093,367
1,119,840
818,339
830,707
670,996
759,460
759,463
749,928
674,324
576,475
576,475674,324749,928759,463759,460670,996830,707818,3391,119,8401,093,3671,167,5941,128,880956,406832,926920,301986,053898,728953,3601,156,8761,098,632984,519873,921980,995718,967548,930460,475440,806389,005387,820378,647395,654414,171402,737351,493432,955372,042280,483201,786179,772198,651206,275202,275238,940278,510268,155292,433351,305307,660332,804315,374327,900334,549291,360359,177352,528437,530360,954475,289321,699282,361236,927370,311
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
619,000
770,000
610,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000610,000770,000619,000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
619,000
770,000
610,000
490,000
415,000
254,950
234,950
235,336
293,361
313,331
362,495
369,178
420,419
422,003
264,239
244,172
244,816
279,819
279,937
209,814
209,814279,937279,819244,816244,172264,239422,003420,419369,178362,495313,331293,361235,336234,950254,950415,000490,000610,000770,000619,000000000000000000000000000000000000000000000
       Accounts payable 
77,753
24,680
43,251
63,839
88,434
35,717
76,127
58,221
64,912
75,699
91,058
100,507
84,760
109,851
98,697
95,504
98,831
89,520
97,218
88,826
74,078
85,072
101,010
78,272
82,543
175,435
211,645
183,166
159,977
239,116
208,109
208,290
186,937
203,380
217,955
200,915
212,432
245,452
347,269
551,111
472,558
291,574
288,608
324,784
283,621
357,988
521,429
599,415
538,675
662,904
749,284
759,734
628,617
634,376
247,095
238,423
238,339
314,157
320,857
256,158
235,223
237,559
237,559235,223256,158320,857314,157238,339238,423247,095634,376628,617759,734749,284662,904538,675599,415521,429357,988283,621324,784288,608291,574472,558551,111347,269245,452212,432200,915217,955203,380186,937208,290208,109239,116159,977183,166211,645175,43582,54378,272101,01085,07274,07888,82697,21889,52098,83195,50498,697109,85184,760100,50791,05875,69964,91258,22176,12735,71788,43463,83943,25124,68077,753
       Other Current Liabilities 
37,088
31,067
14,930
10,930
12,725
10,057
20,603
17,007
19,465
9,069
15,899
31,526
31,747
54,086
63,371
55,209
39,010
34,043
41,700
34,322
37,405
24,546
20,984
25,343
43,086
28,892
30,239
29,632
35,360
31,964
54,406
40,707
45,054
47,783
44,393
68,234
52,586
43,020
53,841
29,728
46,123
167,841
174,568
38,843
39,568
19,292
30,372
24,491
38,957
30,063
61,299
57,216
71,443
73,297
84,525
84,796
87,788
76,775
1,629
57,460
54,318
1,085
1,08554,31857,4601,62976,77587,78884,79684,52573,29771,44357,21661,29930,06338,95724,49130,37219,29239,56838,843174,568167,84146,12329,72853,84143,02052,58668,23444,39347,78345,05440,70754,40631,96435,36029,63230,23928,89243,08625,34320,98424,54637,40534,32241,70034,04339,01055,20963,37154,08631,74731,52615,8999,06919,46517,00720,60310,05712,72510,93014,93031,06737,088
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,830
55,930
54,519
53,036
51,425
52,978
55,246
59,962
71,438
70,141
80,862
95,924
248,245
304,616
290,136
242,333
205,710
167,406
81,509
98,932
98,93281,509167,406205,710242,333290,136304,616248,24595,92480,86270,14171,43859,96255,24652,97851,42553,03654,51955,93058,830000000000000000000000000000000000000000000
       Other Liabilities 
0
1,900
7,200
8,225
8,020
7,750
8,013
7,275
7,500
14,100
18,199
17,659
17,764
19,254
18,781
21,283
20,736
27,159
26,388
39,992
39,096
34,602
34,602
37,806
36,908
36,210
35,202
34,600
33,492
32,698
31,583
29,891
33,082
35,611
34,169
35,660
34,201
32,864
35,102
35,878
38,044
41,958
48,038
45,138
43,727
42,244
51,425
42,186
44,454
49,170
60,646
59,349
61,853
68,943
67,638
56,474
58,867
71,663
0
51,015
49,917
0
049,91751,015071,66358,86756,47467,63868,94361,85359,34960,64649,17044,45442,18651,42542,24443,72745,13848,03841,95838,04435,87835,10232,86434,20135,66034,16935,61133,08229,89131,58332,69833,49234,60035,20236,21036,90837,80634,60234,60239,09639,99226,38827,15920,73621,28318,78119,25417,76417,65918,19914,1007,5007,2758,0137,7508,0208,2257,2001,9000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,372
2,596
10,507
9,123
8,211
7,146
7,620
7,118
6,048
5,355
5,483
4,701
8,109
9,123
12,140
10,622
12,848
13,361
18,677
0
25,102
23,844
0
023,84425,102018,67713,36112,84810,62212,1409,1238,1094,7015,4835,3556,0487,1187,6207,1468,2119,12310,5072,5965,372000000000000000000000000000000000000000
> Total Stockholder Equity
112,530
193,276
238,053
259,729
654,221
662,613
670,964
682,561
694,980
703,113
713,291
732,062
752,592
760,135
773,425
784,075
804,285
817,061
830,569
1,415,341
1,427,984
1,434,513
1,448,977
1,452,362
1,457,133
1,449,403
1,464,763
1,466,700
1,473,787
1,478,115
1,469,284
1,486,902
1,496,348
1,505,332
1,519,679
1,511,878
1,518,365
1,522,850
1,534,118
1,529,006
1,540,897
1,540,020
1,548,150
1,553,922
1,572,546
1,566,998
1,583,828
1,599,829
1,605,550
1,599,359
1,607,521
1,641,572
1,738,327
1,813,232
1,847,823
1,874,362
1,905,912
2,004,343
2,038,361
2,011,882
2,002,544
1,983,486
1,983,4862,002,5442,011,8822,038,3612,004,3431,905,9121,874,3621,847,8231,813,2321,738,3271,641,5721,607,5211,599,3591,605,5501,599,8291,583,8281,566,9981,572,5461,553,9221,548,1501,540,0201,540,8971,529,0061,534,1181,522,8501,518,3651,511,8781,519,6791,505,3321,496,3481,486,9021,469,2841,478,1151,473,7871,466,7001,464,7631,449,4031,457,1331,452,3621,448,9771,434,5131,427,9841,415,341830,569817,061804,285784,075773,425760,135752,592732,062713,291703,113694,980682,561670,964662,613654,221259,729238,053193,276112,530
   Common Stock
30,200
60,000
60,000
60,000
80,000
80,000
80,000
104,000
104,000
104,000
104,000
104,000
104,000
104,000
104,000
135,200
135,200
135,200
135,200
184,628
184,628
184,628
184,628
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
369,256
371,912
371,912
371,912
371,912
371,813
0
370,771
370,771
0
0370,771370,7710371,813371,912371,912371,912371,912369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256369,256184,628184,628184,628184,628135,200135,200135,200135,200104,000104,000104,000104,000104,000104,000104,000104,00080,00080,00080,00060,00060,00060,00030,200
   Retained Earnings 
67,952
11,638
51,937
73,612
82,818
87,284
95,475
105,512
117,931
121,808
131,986
150,757
171,286
171,958
185,248
195,899
216,109
222,156
235,657
220,443
233,086
235,193
280,358
283,742
288,514
280,584
295,943
297,822
304,907
309,308
300,477
317,634
327,260
336,495
350,598
343,263
349,749
356,577
370,850
360,377
367,170
366,297
328,149
331,164
346,915
390,453
404,475
422,768
433,046
429,237
438,065
471,627
567,410
608,661
651,384
677,098
696,924
719,521
647,287
722,681
735,910
648,203
648,203735,910722,681647,287719,521696,924677,098651,384608,661567,410471,627438,065429,237433,046422,768404,475390,453346,915331,164328,149366,297367,170360,377370,850356,577349,749343,263350,598336,495327,260317,634300,477309,308304,907297,822295,943280,584288,514283,742280,358235,193233,086220,443235,657222,156216,109195,899185,248171,958171,286150,757131,986121,808117,931105,51295,47587,28482,81873,61251,93711,63867,952
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,349
3,641
3,606
1,479
4,236
7,109
6,428
9,235
6,943
2,387
5
-661
-1,315
-409
29,796
16,857
12,886
19,830
96,771
0
98,045
74,560
0
074,56098,045096,77119,83012,88616,85729,796-409-1,315-66152,3876,9439,2356,4287,1094,2361,4793,6063,641-1,349000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,523,914
Cost of Revenue-2,319,382
Gross Profit204,532204,532
 
Operating Income (+$)
Gross Profit204,532
Operating Expense-2,431,840
Operating Income92,074-2,227,308
 
Operating Expense (+$)
Research Development11,299
Selling General Administrative50,067
Selling And Marketing Expenses-
Operating Expense2,431,84061,366
 
Net Interest Income (+$)
Interest Income5,454
Interest Expense-22,678
Other Finance Cost-1,561
Net Interest Income-18,785
 
Pretax Income (+$)
Operating Income92,074
Net Interest Income-18,785
Other Non-Operating Income Expenses-
Income Before Tax (EBT)65,11592,074
EBIT - interestExpense = -22,678
53,969
76,647
Interest Expense22,678
Earnings Before Interest and Taxes (EBIT)-87,793
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax65,115
Tax Provision-11,146
Net Income From Continuing Ops53,96953,969
Net Income53,969
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-18,785
 

Technical Analysis of Baolingbao Biology Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Baolingbao Biology Co Ltd. The general trend of Baolingbao Biology Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Baolingbao Biology Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Baolingbao Biology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 5.5821872193437 < 5.99 < 6.49.

The bearish price targets are: 4.5663816793893.

Tweet this
Baolingbao Biology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Baolingbao Biology Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Baolingbao Biology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Baolingbao Biology Co Ltd. The current macd is -0.16624406.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Baolingbao Biology Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Baolingbao Biology Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Baolingbao Biology Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Baolingbao Biology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBaolingbao Biology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Baolingbao Biology Co Ltd. The current adx is 24.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Baolingbao Biology Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Baolingbao Biology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Baolingbao Biology Co Ltd. The current sar is 6.2280967.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Baolingbao Biology Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Baolingbao Biology Co Ltd. The current rsi is 38.06. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Baolingbao Biology Co Ltd Daily Relative Strength Index (RSI) ChartBaolingbao Biology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Baolingbao Biology Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Baolingbao Biology Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Baolingbao Biology Co Ltd Daily Stochastic Oscillator ChartBaolingbao Biology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Baolingbao Biology Co Ltd. The current cci is -145.79745797.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Baolingbao Biology Co Ltd Daily Commodity Channel Index (CCI) ChartBaolingbao Biology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Baolingbao Biology Co Ltd. The current cmo is -29.18735882.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Baolingbao Biology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartBaolingbao Biology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Baolingbao Biology Co Ltd. The current willr is -76.47058824.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Baolingbao Biology Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Baolingbao Biology Co Ltd Daily Williams %R ChartBaolingbao Biology Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Baolingbao Biology Co Ltd.

Baolingbao Biology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Baolingbao Biology Co Ltd. The current atr is 0.26188439.

Baolingbao Biology Co Ltd Daily Average True Range (ATR) ChartBaolingbao Biology Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Baolingbao Biology Co Ltd. The current obv is -32,243,848.

Baolingbao Biology Co Ltd Daily On-Balance Volume (OBV) ChartBaolingbao Biology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Baolingbao Biology Co Ltd. The current mfi is 40.82.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Baolingbao Biology Co Ltd Daily Money Flow Index (MFI) ChartBaolingbao Biology Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Baolingbao Biology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Baolingbao Biology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Baolingbao Biology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.061
Ma 20Greater thanMa 506.039
Ma 50Greater thanMa 1005.904
Ma 100Greater thanMa 2006.898
OpenGreater thanClose5.500
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Baolingbao Biology Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Baolingbao Biology Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Baolingbao Biology Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Baolingbao Biology Co Ltd

I send you an email if I find something interesting about Baolingbao Biology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Baolingbao Biology Co Ltd.

Receive notifications about Baolingbao Biology Co Ltd in your mailbox!